Ana Catarina Urbano

Dr. Ana Catarina Urbano

Faculdade de Medicina Veterinária da Universidade de Lisboa (FMV-Ulisboa)
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AUAna Catarina Urbano
Ana Catarina Urbano
Catarina NascimentoCatarina Nascimento
Catarina Nascimento
MSMaria Soares
Maria Soares
Jorge CorreiaJorge Correia
Jorge Correia
Fernando FerreiraFernando Ferreira
Fernando Ferreira
Cytotoxic T lymphocyte associated antigen 4 (CTLA-4) serves an important role in breast cancer progression, which has led to the development of novel immunotherapies aimed at blocking tumor immune evasion. Although feline mammary carcinoma is increasingly recognized as a valuable cancer model, no studies on CTLA-4 function had been conducted in this species. The serum CTLA-4, TNF-α and IL-6 levels of 57 female cats with mammary carcinoma were determined by ELISA, and immunohistochemistry was performed to evaluate CTLA-4 and FoxP3 expression in tumor cells and interstitial lymphocytes. The results obtained show that serum CTLA-4 levels are increased in cats with mammary carcinoma (P = 0.022), showing an association with a number of clinicopathological features: smaller tumor size, P < 0.001; absence of tumor necrosis, P < 0.001; non-basal status, P < 0.02 and HER-2-positive status. Additionally, a strong positive correlation was found between serum CTLA-4 levels and serum TNF-α (R = 0.88, P < 0.001) and IL-6 levels (R = 0.72, P < 0.001). Concerning the CTLA-4 and FoxP3 expression, although detected in both interstitial lymphocytes and tumor cells, a positive association was found only between interstitial CTLA-4 and FoxP3 expressions (R = 0.387, P = 0.01), which is negatively associated with the serum CTLA-4 levels (P = 0.03). These findings provide a preliminary step in the characterization of immune profiles in feline mammary carcinoma, uncovering a molecular rationale for targeted therapy with CTLA-4 pathway inhibitors. Finally, by strengthening the hypothesis of an immunomodulatory role for this regulator, we further validate the utility of spontaneous feline mammary carcinoma as a model for human breast cancer.

14 January 2025 in FEMS Microbiology Reviews
Verified
Journal Article
Open access
AUAna Catarina Urbano
Ana Catarina Urbano
BMBeatriz Melo
Beatriz Melo
Fernando FerreiraFernando Ferreira
Fernando Ferreira
African swine fever (ASF), caused by the highly contagious African swine fever virus (ASFV), poses a significant threat to domestic and wild pigs worldwide. Despite its limited host range and lack of zoonotic potential, ASF has severe socio-economic and environmental consequences. Current control strategies primarily rely on early detection and culling of infected animals, but these measures are insufficient given the rapid spread of the disease. Developing effective therapeutics against ASFV is crucial to prevent further spread and mitigate economic losses. Although vaccination remains critical, recent vaccine approvals in Vietnam have raised safety and efficacy concerns. Moreover, as challenges persist in vaccine development and deployment, particularly in complex field conditions, antiviral agents have emerged as a critical complementary approach. These agents have the potential to mitigate side effects and control viral spread when vaccines alone are insufficient or when animals face simultaneous exposure to vaccine strains and wild-type viruses. However, advancing them from proof-of-concept to widespread practical application entails a significant interdisciplinary effort, given the logistical and economic constraints of in vivo testing. In this review, we examine emerging antiviral approaches and highlight key ASFV replication mechanisms and therapeutic targets to guide rational drug design amidst an evolving viral landscape.

3 October 2020 in Vaccines
Verified
Journal Article
Open access
PDF file
AUAna Catarina Urbano
Ana Catarina Urbano
Fernando FerreiraFernando Ferreira
Fernando Ferreira
The recent incursions of African swine fever (ASF), a severe, highly contagious, transboundary viral disease that affects members of the Suidae family, in Europe and China have had a catastrophic impact on trade and pig production, with serious implications for global food security. Despite efforts made over past decades, there is no vaccine or treatment available for preventing and controlling the ASF virus (ASFV) infection, and there is an urgent need to develop novel strategies. Genome condensation and packaging are essential processes in the life cycle of viruses. The involvement of viral DNA-binding proteins in the regulation of virulence genes, transcription, DNA replication, and repair make them significant targets. pA104R is a highly conserved HU/IHF-like DNA-packaging protein identified in the ASFV nucleoid that appears to be profoundly involved in the spatial organization and packaging of the ASFV genome. Here, we briefly review the components of the ASFV packaging machinery, the structure, function, and phylogeny of pA104R, and its potential as a target for vaccine and drug development.

11 August 2021 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
AGAndreia Gameiro
Andreia Gameiro
AUAna Catarina Urbano
Ana Catarina Urbano
Fernando FerreiraFernando Ferreira
Fernando Ferreira
Feline mammary carcinoma (FMC) is a common aggressive malignancy with a low survival rate that lacks viable therapeutic options beyond mastectomy. Recently, increasing efforts have been made to understand the molecular mechanisms underlying FMC development, using the knowledge gained from studies on human breast cancer to discover new diagnostic and prognostic biomarkers, thus reinforcing the utility of the cat as a cancer model. In this article, we review the current knowledge on FMC pathogenesis, biomarkers, and prognosis factors and offer new insights into novel therapeutic options for HER2-positive and triple-negative FMC subtypes.

27 April 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
Catarina NascimentoCatarina Nascimento
Catarina Nascimento
AUAna Catarina Urbano
Ana Catarina Urbano
AGAndreia Gameiro
Andreia Gameiro
JFJoão António Ferreira
João António Ferreira
Jorge CorreiaJorge Correia
Jorge Correia
Fernando FerreiraFernando Ferreira
Fernando Ferreira
Tumor microenvironment has gained great relevance due to its ability to regulate distinct checkpoints mediators, orchestrating tumor progression. In order to understand the role of the PD- 1/PD-L1 axis in cats with mammary carcinoma, serum PD-1 and PD-L1 levels were compared with healthy controls and with serum CTLA-4 and TNF- α levels. PD-1 and PD-L1 expression was evaluated in TILs and cancer cells, as the presence of somatic mutations. Results showed that serum PD-1 and PD-L1 levels were significantly higher in cats with HER2-positive (p=0.017; p=0.032) and triple negative (TN) normal-like mammary carcinomas (p=0.004; p=0.015). Besides, cats presenting these tumor subtypes showed a strong positive correlation between serum PD-1, PD-L1, CTLA-4 and TNF- α levels. In tumors, PD-L1 expression in cancer cells was significantly higher in HER2-positive samples than in TN normal-like tumors (p=0.010), as the percentage of PD-L1-positive TILs (p=0.038). Results from the PD-L1 gene sequencing identified two heterozygous mutations in exon 4 (A245T, 3.8%; V252M, 42.3%) and one in exon 5 (T267S, 3.8%). In summary, results support that serum PD-1 and PD-L1 levels can be used as diagnostic biomarkers of HER2-positive and TN normal-like feline mammary carcinomas and suggest that the development of monoclonal antibodies may be a good therapeutic strategy.

8 February 2026 in Emerging Microbes & Infections
Verified
Journal Article
Open access
NJNuno Jordão
Nuno Jordão
AUAna Catarina Urbano
Ana Catarina Urbano
FBFernando Boinas
Fernando Boinas
CMCarlos Martins
Carlos Martins
Fernando FerreiraFernando Ferreira
Fernando Ferreira
African Swine Fever virus (ASFV) causes a contagious and fatal disease in domestic pigs and Eurasian wild boars, representing a serious threat to the global pig industry, since no antivirals are available and vaccine use is currently restricted to Vietnam. Notably, ASFV encodes for an E2 ubiquitin-conjugating enzyme (ASFV-pI215L) which is essential for viral replication and evasion from immune interferon type I responses, suggesting that its functional impairment could lead to a live attenuated vaccine. In this study, we showed that ASFV-pI215L is highly conserved among 222 ASFV isolates, including the emerging ones, emphasizing its value as a target for vaccine design. Furthermore, our mutagenic studies revealed that single- and multiple-residue substitutions comprising the R11-E15 and D130-S134 residues reduced ASFV-pI215L E2 ubiquitin-conjugating activity. In parallel, a strong immunodominant B-cell epitope was mapped and mutated between P61 and F69 resides, reducing or abolishing both IgG and IgM recognition, and ASFV-pI215L E2 activity. In sum, this study highlights that rational targeted mutagenesis can reduce E2 ubiquitin-conjugating activity and immune recognition of ASFV-pI215L, providing a strategy to develop an attenuated vaccine able to differentiate infected from vaccinated animals.